Military and civilian market Target expansion opportunities by emphasizing HemCon's roots in hemostatic solutions for military, civilian, and consumer medical markets. Develop campaigns addressing trauma care, field hospitals, emergency response, and civilian first aid channels where rapid hemostasis is critical.

Chitosan heritage Leverage HemCon’s chitosan-based technology as a differentiator to approach wound care, hemostatic dressings, and rapid clotting products for EMS, ambulatory clinics, and operating rooms. Propose partnerships or pilot programs to validate performance in high-need settings.

Small but nimble Position as a specialized, agile supplier able to customize or shorten lead times for niche medical devices. Highlight the potential for co-development, private labeling, or targeted product enhancements to fit specific customer workflows.

Growth through acquisitions Given historical acquisition activity, explore strategic partnerships or recurring supply agreements with larger distributors or manufacturers seeking complementary hemostatic or wound-care technologies to broaden product portfolios.

Financial opportunity in mid-market Note revenue in the lower mid-market tier and pursue mid-size hospital systems, outpatient surgical centers, and military medical procurement programs as attainable customers. Emphasize value proposition, cost-per-use effectiveness, and potential return on investment for procurement teams.